Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 1
1970 1
1973 5
1974 1
1975 2
1976 5
1977 6
1978 6
1979 1
1981 2
1985 1
1986 1
1989 2
1990 1
1991 4
1992 1
1993 4
1994 2
1995 1
1996 3
1997 1
1998 4
1999 4
2000 6
2001 5
2002 6
2003 6
2004 6
2005 5
2006 7
2007 3
2008 2
2009 1
2010 8
2011 7
2012 12
2013 6
2014 1
2015 2
2016 4
2017 9
2018 2
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
[Leukopenia investigations].
Nousiainen T. Nousiainen T. Duodecim. 1998;114(12):1195-201. Duodecim. 1998. PMID: 11524765 Review. Finnish. No abstract available.
[Gaucher disease].
Timonen T, Möttönen M, Nousiainen T, Herva R, Savolainen ER. Timonen T, et al. Among authors: nousiainen t. Duodecim. 2005;121(19):2068-76. Duodecim. 2005. PMID: 16300295 Review. Finnish. No abstract available.
[Burkitt's leukemia-lymphoma].
Jantunen E, Vornanen M, Nousiainen T, Riikonen P. Jantunen E, et al. Among authors: nousiainen t. Duodecim. 1995;111(22):2115-21. Duodecim. 1995. PMID: 9841171 Review. Finnish. No abstract available.
[Forwards together].
Nousiainen T. Nousiainen T. Sairaanhoitaja. 1973 Jun 12;49(10):51. Sairaanhoitaja. 1973. PMID: 4490050 Swedish. No abstract available.
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Kolonen A, Sinisalo M, Huhtala H, Rimpiläinen J, Rintala H, Sankelo M, Koivunen E, Silvennoinen R, Räty R, Ruutu T, Volin L, Porkka K, Jantunen E, Nousiainen T, Kuittinen T, Penttilä K, Pyörälä M, Säily M, Koistinen P, Kauppila M, Itälä-Remes M, Ollikainen H, Rauhala A, Kairisto V, Pelliniemi TT, Elonen E; Finnish Leukemia Group. Kolonen A, et al. Among authors: nousiainen t. Eur J Haematol. 2022 Sep;109(3):257-270. doi: 10.1111/ejh.13805. Epub 2022 Jun 14. Eur J Haematol. 2022. PMID: 35634931 Clinical Trial.
155 results